scholarly journals miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib

2019 ◽  
Vol Volume 12 ◽  
pp. 6825-6838 ◽  
Author(s):  
Leisheng Wang ◽  
He En ◽  
Lei Yang ◽  
Yanbing Zhang ◽  
Baisheng Sun ◽  
...  
Keyword(s):  
Molecular Targeting ◽  
Osteosarcoma Cells ◽  
Molecular Targeting Agent

scholarly journals Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer

2014 ◽  
Vol 7 (1) ◽  
pp. 38 ◽  
Author(s):  
Hiroshi Kawaguchi ◽  
Yoshito Terai ◽  
Akiko Tanabe ◽  
Hiroshi Sasaki ◽  
Masaaki Takai ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Molecular Targeting ◽  
Platinum Resistant ◽  
Molecular Targeting Agent

Evidence for erythropoietin as a molecular targeting agent

2002 ◽  
Vol 29 (3 Suppl 11) ◽  
pp. 145-154 ◽  
Author(s):  
Brian Leyland-Jones
Keyword(s):  
Molecular Targeting ◽  
Molecular Targeting Agent

Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells via the miR-148a/PXR axis

2021 ◽  
Author(s):  
Boan Li ◽  
Fan Feng ◽  
Hui Jia ◽  
Qiyu Jiang ◽  
Shuang Cao ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Drug Resistance ◽  
Antitumor Effect ◽  
Pregnane X Receptor ◽  
Carcinoma Cells ◽  
Molecular Targeting ◽  
Hepatocellular Carcinoma Cells ◽  
Molecular Targeting Agent

The pregnane X receptor (PXR) mediates the resistance of sorafenib in hepatocellular carcinoma (HCC) by promoting the clearance or elimination of sorafenib via the drug resistance-related downstream genes of the PXR. Rhamnetin drepresses the activation of PXR via miR-148a.

scholarly journals Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers

2010 ◽  
Vol 10 (11) ◽  
pp. 1137-1146 ◽  
Author(s):  
Satoshi Tsunetoh ◽  
Yoshito Terai ◽  
Hiroshi Sasaki ◽  
Akiko Tanabe ◽  
Yoshimichi Tanaka ◽  
...  
Keyword(s):  
Molecular Targeting ◽  
Ovarian Cancers ◽  
Platinum Resistant ◽  
Molecular Targeting Agent

Introduction of chemotherapy (Molecular targeting agent・Chemotherapy)

Toukeibu Gan ◽  
2016 ◽  
Vol 42 (3) ◽  
pp. 309-315
Author(s):  
Yuichi Ando ◽  
Akiko Ota ◽  
Rie Tsuboi
Keyword(s):  
Molecular Targeting ◽  
Molecular Targeting Agent
Sign in / Sign up

Export Citation Format

Share Document